These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2662351)

  • 81. Erratum to: Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2016 Feb; 15():59. PubMed ID: 26846930
    [No Abstract]   [Full Text] [Related]  

  • 82. Evidence of Self-Medication with Chloroquine before Consultation for Malaria in the Southern Pacific Coast Region of Colombia.
    Diaz G; Lasso AM; Murillo C; Montenegro LM; Echeverry DF
    Am J Trop Med Hyg; 2019 Jan; 100(1):66-71. PubMed ID: 30457089
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.
    Valdes A; Epelboin L; Mosnier E; Walter G; Vesin G; Abboud P; Melzani A; Blanchet D; Blaise N; Nacher M; Demar M; Djossou F
    Malar J; 2018 Jun; 17(1):237. PubMed ID: 29921273
    [TBL] [Abstract][Full Text] [Related]  

  • 84.
    Rodrigues-da-Silva RN; Soares IF; Lopez-Camacho C; Martins da Silva JH; Perce-da-Silva DS; Têva A; Ramos Franco AM; Pinheiro FG; Chaves LB; Pratt-Riccio LR; Reyes-Sandoval A; Banic DM; Lima-Junior JD
    Front Immunol; 2017; 8():77. PubMed ID: 28223984
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana.
    Faway E; Musset L; Pelleau S; Volney B; Casteras J; Caro V; Menard D; Briolant S; Legrand E
    Malar J; 2016 Nov; 15(1):540. PubMed ID: 27825387
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.
    Rodrigues-da-Silva RN; Martins da Silva JH; Singh B; Jiang J; Meyer EV; Santos F; Banic DM; Moreno A; Galinski MR; Oliveira-Ferreira J; Lima-Junior Jda C
    PLoS One; 2016; 11(1):e0146951. PubMed ID: 26788998
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Emerging Plasmodium vivax resistance to chloroquine in South America: an overview.
    Gonçalves LA; Cravo P; Ferreira MU
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):534-9. PubMed ID: 25184999
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Imperfect duplicate insertions type of mutations in plasmepsin V modulates binding properties of PEXEL motifs of export proteins in Indian Plasmodium vivax.
    Rawat M; Vijay S; Gupta Y; Tiwari PK; Sharma A
    PLoS One; 2013; 8(3):e60077. PubMed ID: 23555891
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1).
    Bueno LL; Lobo FP; Morais CG; Mourão LC; de Ávila RA; Soares IS; Fontes CJ; Lacerda MV; Chavez Olórtegui C; Bartholomeu DC; Fujiwara RT; Braga EM
    PLoS One; 2011; 6(6):e21289. PubMed ID: 21713006
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Resistance to therapies for infection by Plasmodium vivax.
    Baird JK
    Clin Microbiol Rev; 2009 Jul; 22(3):508-34. PubMed ID: 19597012
    [TBL] [Abstract][Full Text] [Related]  

  • 91. History, dynamics, and public health importance of malaria parasite resistance.
    Talisuna AO; Bloland P; D'Alessandro U
    Clin Microbiol Rev; 2004 Jan; 17(1):235-54. PubMed ID: 14726463
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
    Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
    Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy.
    Arias AE; Corredor A
    Trop Med Parasitol; 1989 Mar; 40(1):21-3. PubMed ID: 2662351
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia.
    Zuluaga-Idárraga L; Blair S; Akinyi Okoth S; Udhayakumar V; Marcet PL; Escalante AA; Alexander N; Rojas C
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4610-9. PubMed ID: 27185794
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.